352
Participants
Start Date
November 30, 2005
Primary Completion Date
November 30, 2007
Study Completion Date
November 30, 2007
Levetiracetam 250 mg
"* Active Substance: Levetiracetam~* Pharmaceutical Form: Film-coated tablet~* Concentration: 250 mg~* Route of Administration: Oral Use"
Levetiracetam 500 mg
"* Active Substance: Levetiracetam~* Pharmaceutical Form: Film-coated tablet~* Concentration: 500 mg~* Route of Administration: Oral Use"
Placebo
"* Active Substance: Placebo~* Pharmaceutical Form: Film-coated tablet~* Concentration: 250 mg and 500 mg~* Route of Administration: Oral Use"
Aichi-gun
Nagoya
Nayoga
Hirosaki
Chiba
Fukuoka
Kitakyushu
Kurume
Gifu
Fukuyama
Hiroshima
Asahikawa
Hakodate
Sapporo
Kobe
Kahoku-gun
Kagoshima
Kikuchi-gun
Kyoto
Sendai
Miyazaki
Nagaoka
Ōmura
Niigata
Okayama
Izumi
Neyagawa
Osaka
Suita
Shizuoka
Kawachi-gun
Kodaira
Tokyo
Toyama
Yamagata
Ube
Kobe
UCB Japan Co. Ltd.
INDUSTRY